The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-2-([1,1'-biphenyl]-4-ylmethylene)-N-(4-methoxyphenyl)-hydrazinecarbothioamide ID: ALA4291222
PubChem CID: 9715006
Max Phase: Preclinical
Molecular Formula: C21H19N3OS
Molecular Weight: 361.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(NC(=S)N/N=C/c2ccc(-c3ccccc3)cc2)cc1
Standard InChI: InChI=1S/C21H19N3OS/c1-25-20-13-11-19(12-14-20)23-21(26)24-22-15-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h2-15H,1H3,(H2,23,24,26)/b22-15+
Standard InChI Key: IMCCYPMIEKKUMP-PXLXIMEGSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
28.4622 -16.6910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4629 -17.5100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1715 -17.9171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8797 -17.5063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8750 -16.6841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1659 -16.2808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1616 -15.4636 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8671 -15.0512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8627 -14.2341 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
30.5769 -15.4561 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2825 -15.0437 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.9923 -15.4486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6979 -15.0362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4057 -15.4453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1107 -15.0337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1068 -14.2156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3920 -13.8110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6899 -14.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1732 -18.7343 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.4663 -19.1443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8110 -13.8019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5217 -14.2075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2262 -13.7949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2212 -12.9769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5058 -12.5732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8043 -12.9881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
8 9 2 0
8 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
3 19 1 0
19 20 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
16 21 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 361.47Molecular Weight (Monoisotopic): 361.1249AlogP: 4.68#Rotatable Bonds: 5Polar Surface Area: 45.65Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.41CX Basic pKa: 2.57CX LogP: 5.40CX LogD: 5.40Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.39Np Likeness Score: -1.54
References 1. Sens L, de Souza ACA, Pacheco LA, Menegatti ACO, Mori M, Mascarello A, Nunes RJ, Terenzi H.. (2018) Synthetic thiosemicarbazones as a new class of Mycobacterium tuberculosis protein tyrosine phosphatase A inhibitors., 26 (21): [PMID:30389409 ] [10.1016/j.bmc.2018.10.030 ]